The abnormal chronic activation of the NLRP3 inflammasome is implicated in the onset of various diseases, including the metabolic syndrome, T1DM, T2DM, gout, Alzheimer’s disease, and atherosclerosis [128, 129]. Here, NLRP3 is linked to type 2 diabetes mellitus.